Tower Research Capital (TRC)’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$21.6K	Buy	1,941 +844	+77%	+$10.7K	﹤0.01%	3432
2025 Q4	$18.2K	Sell	1,097 -465	-30%	-$6.64K	﹤0.01%	3169
2025 Q3	$18.4K	Sell	1,562 -4,148	-73%	-$42.8K	﹤0.01%	3387
2025 Q2	$54.8K	Buy	5,710 +2,102	+58%	+$11.6K	﹤0.01%	2898
2025 Q1	$22.6K	Sell	3,608 -806	-18%	-$4.89K	﹤0.01%	2844
2024 Q4	$35.8K	Buy	4,414 +27	+0.6%	+$334	﹤0.01%	2779
2024 Q3	$79.3K	Sell	4,387 -1,426	-25%	-$19.9K	﹤0.01%	2418
2024 Q2	$59.9K	Buy	5,813 +5,233	+902%	+$53.9K	﹤0.01%	2956
2024 Q1	$6.16K	Sell	580 -9,281	-94%	-$78.8K	﹤0.01%	4422
2023 Q4	$90K	Buy	9,861 +550	+6%	+$4.74K	﹤0.01%	2726
2023 Q3	$96.6K	Buy	9,311 +8,834	+1,852%	+$121K	﹤0.01%	2007
2023 Q2	$6.83K	Sell	477 -1,228	-72%	-$14.2K	﹤0.01%	4655
2023 Q1	$12K	Buy	1,705 +1,219	+251%	+$10.7K	﹤0.01%	4112
2022 Q4	$5K	Sell	486 -3,965	-89%	-$40.9K	﹤0.01%	4896
2022 Q3	$49K	Sell	4,451 -929	-17%	-$8.85K	﹤0.01%	3174
2022 Q2	$45K	Buy	5,380 +1,684	+46%	+$17.3K	﹤0.01%	2991
2022 Q1	$51K	Buy	3,696 +3,280	+788%	+$53K	﹤0.01%	2715
2021 Q4	$8K	Sell	416 -190	-31%	-$4.47K	﹤0.01%	4816
2021 Q3	$19K	Sell	606 -3,227	-84%	-$107K	﹤0.01%	3769
2021 Q2	$130K	Buy	3,833 +2,517	+191%	+$90.1K	﹤0.01%	2214
2021 Q1	$49K	Sell	1,316 -841	-39%	-$35.2K	﹤0.01%	3150
2020 Q4	$72K	Sell	2,157 -9,055	-81%	-$367K	﹤0.01%	2695
2020 Q3	$411K	Buy	11,212 +9,058	+421%	+$314K	﹤0.01%	1901
2020 Q2	$71K	Buy	+2,154	New	+$82.8K	﹤0.01%	2763